|questions about IL-2
Mar 7, 2005
Thank you for pointing out the conclusion that people who start therapy with higher CD4 counts may be able to interrupt therapy longer.
However my question was about how long IL-2 helped people to interrupt therapy.
Would it be possible to answer the questions I asked?
Did your study indicate that prior to week 72 more people not on IL-2 had to go on back on HAART, but after week 72 the people on IL-2 had to go back on HAART in so much larger numbers that they "caught up" and so by say week 78 equal numbers of Il-2 and non IL-2 patients were back on therapy? Or is it saying that up to week 72 the IL-2 patients did better at staying off therapy and between say week 72 and week 78 equal numbers went back on therapy?
What percentage were off therapy at 78 weeks?
Response from Dr. Henry
There was no statistically significant benefit of IL-2 after 72 weeks in our study. Both arms (the IL-2 and the control arm without IL-2) had the same high percentage (> 50%) still off treatment (CD4 > 350) after 72 weeks. If the data was analyzed before week 72 the erroneous conclusion would have been that the IL-2 group stayed off therapy longer but with the long follow-up the benefit of IL-2 waned. KH
Keletra & Heart Issues
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.